Recent studies have reported that people who suffer from diabetes, had a significantly reduced risk of death from Ovid-i9 complications, when
they took the medicatıon mettormın.
- This data was analyzed from a diverse patient population, where researchers compared two controlled groups of individuals and found that those
who had been taking metformin (a drug designed for type 2 diabetes), were less likely to die of COVID-19 than those who were not taking metformin.
The Frontiers in Endocrinology journal was the first to publish these findıngs.
Source:- https://www.emedevents.com/blogs/medblogpage/endocrinologists-discover-m...
Recent studies have reported that people who suffer from diabetes, had a significantly reduced risk of death from Ovid-i9 complications, when
they took the medicatıon mettormın.
- This data was analyzed from a diverse patient population, where researchers compared two controlled groups of individuals and found that those
who had been taking metformin (a drug designed for type 2 diabetes), were less likely to die of COVID-19 than those who were not taking metformin.
The Frontiers in Endocrinology journal was the first to publish these findıngs.